Drug Information

Drug General Information
Drug ID
D0V1CL
Former ID
DNC004226
Drug Name
Cartazolate
Drug Type
Small molecular drug
Indication Discovery agent Investigative [526024]
Formula
C15H22N4O2
Canonical SMILES
CCCCNC1=C2C=NN(C2=NC=C1C(=O)OCC)CC
InChI
1S/C15H22N4O2/c1-4-7-8-16-13-11-10-18-19(5-2)14(11)17-9-12(13)15(20)21-6-3/h9-10H,4-8H2,1-3H3,(H,16,17)
InChIKey
IQNQAOGGWGCROX-UHFFFAOYSA-N
CAS Number
CAS 34966-41-1
PubChem Compound ID
37015
Target and Pathway
Target(s) CGMP-specific 3',5'-cyclic phosphodiesterase Target Info Inhibitor [526024]
KEGG Pathway Purine metabolism
cGMP-PKG signaling pathway
NetPath Pathway TGF_beta_Receptor Signaling Pathway
Reactome cGMP effects
References
Ref 526024J Med Chem. 2001 Mar 29;44(7):1025-7.Substituted pyrazolopyridines as potent and selective PDE5 inhibitors: potential agents for treatment of erectile dysfunction.
Ref 526024J Med Chem. 2001 Mar 29;44(7):1025-7.Substituted pyrazolopyridines as potent and selective PDE5 inhibitors: potential agents for treatment of erectile dysfunction.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.